Plasma chondroitin sulfate predicts the effectiveness of fluid resuscitation strategies in patients with sepsis
Journal of Clinical Investigation · 2026
DOI: 10.1172/jci202480 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Kaori Oshima und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Mass General Brigham, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Chondroitin Sulfates, Sepsis, Fluid Therapy, Resuscitation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.
Themen: Reanimation, Sepsis
Abstract (Originalsprache)
BACKGROUND Plasma heparan sulfate, a glycosaminoglycan released during endothelial glycocalyx degradation, predicts sepsis mortality. Chondroitin sulfate is a circulating glycosaminoglycan not specific to glycocalyx degradation; its relevance to sepsis is unknown. METHODS We studied the associations of plasma chondroitin sulfate with (a) mortality in patients with sepsis-associated hypotension and (b) the relative effectiveness of a randomly assigned liberal versus restrictive intravenous fluid resuscitation strategy. We selected 574 patients enrolled in the Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis trial using an outcome-enriched sampling strategy. We used liquid chromatography–mass spectrometry to quantify plasma chondroitin sulfate. In comparison, we measured hyaluronic acid as a glycocalyx degradation marker and IL-6 as an inflammatory biomarker. We conducted Cox proportional hazards regression analyses to examine associations of baseline biomarker concentrations with mortality and resuscitation strategy effectiveness. We used inverse probability of selection weights and generalized raking to account for the nonrepresentative sampling design. RESULTS Plasma chondroitin sulfate, hyaluronic acid, and IL-6 were associated with mortality within 90 days. As baseline chondroitin sulfate increased, subsequent randomization to a restrictive strategy was increasingly beneficial ( P = 0.022): treatment effect hazard ratio (restrictive versus liberal) for mortality was estimated as 1.49 (95% CI, 0.98–2.27), 1.30 (95% CI, 1.00–1.69), 1.09 (95% CI, 0.82–1.44), 0.88 (95% CI, 0.66–1.16), and 0.71 (95% CI, 0.52–0.97) for 10th, 25th, 50th, 75th, and 90th percentiles of baseline chondroitin sulfate. CONCLUSION Plasma chondroitin sulfate predicts sepsis mortality and may modify the response to a subsequent liberal versus restrictive intravenous fluid resuscitation strategy. TRIAL REGISTRATION ClinicalTrials.gov NCT03434028. FUNDING NIH grants R01HL149422 and R01HL094786.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Mass General Brigham, Boston, Massachusetts, USA.
- Department of Biostatistics and.
- Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
- Department of Medicine, University of Colorado, Aurora, Colorado, USA.
- Department of Emergency Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
Förderung
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
Zitieren
APA
Oshima, K., Yan, B., Tao, R., Amorim, G., Di Gravio, C., McMurtry, S. A., Burke, R. C., Nam, Y., Nikolli, I., Kravitz, M. S., Stephenson, D., Issaian, A., Hansen, K. C., D'Alessandro, A., Douglas, I. S., Self, W. H., Lindsell, C. J., Leroux, C., Ringor, A., …, & Schmidt, E. P. (2026). Plasma chondroitin sulfate predicts the effectiveness of fluid resuscitation strategies in patients with sepsis. Journal of Clinical Investigation. https://doi.org/10.1172/jci202480
Vancouver
Oshima K, Yan B, Tao R, Amorim G, Di Gravio C, McMurtry SA, et al. Plasma chondroitin sulfate predicts the effectiveness of fluid resuscitation strategies in patients with sepsis. Journal of Clinical Investigation. 2026. doi:10.1172/jci202480
BibTeX
@article{Oshima2026,
author = {Oshima, Kaori and Yan, Bailu and Tao, Ran and Amorim, Gustavo and Di Gravio, Chiara and McMurtry, Sarah A and Burke, Ryan C and Nam, Yunbi and Nikolli, Ina and Kravitz, Max S and Stephenson, Daniel and Issaian, Aaron and Hansen, Kirk C and D'Alessandro, Angelo and Douglas, Ivor S and Self, Wesley H and Lindsell, Christopher J and Leroux, Carolyn and Ringor, Angelika and Matthay, Michael A and Schildcrout, Jonathan S and Shapiro, Nathan I and Schmidt, Eric P},
title = {Plasma chondroitin sulfate predicts the effectiveness of fluid resuscitation strategies in patients with sepsis},
journal = {Journal of Clinical Investigation},
year = {2026},
doi = {10.1172/jci202480}
}
EUVIMED